Jahan A Rahman (Jahan Rahman)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Histone Deacetylase

Acute Lymphoblastic Leukemia

Cell Proliferation

Top Venues

Cancer immunology research

Research square

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Winson Cai, Kento Tanaka, Xiaoli Mi, Vinagolu K Rajasekhar, Jonathan F Khan, Sarah Yoo, Elisa De Stanchina, Jahan A Rahman, Serena Mathew, Parwiz Abrahimi, Sydney Souness, Terence J Purdon, James R McDowell, Jeremy Meyerberg, Takeshi Fujino, John H Healey, Omar Abdel-Wahab, David A Scheinberg, Renier J Brentjens, Anthony F Daniyan
Augmenting CAR T Cell Functions with LIGHT. Cancer immunology research (2024)
Juan C Osorio, David Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez, Meghan DiLillo, Jahan A Rahman, Jacqueline F Bromberg, Michael A Postow, Charlotte E Ariyan, Mark E Robson, Jeffrey V Ravetch
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer. Research square (2024)
Steven M Horwitz, Ajit J Nirmal, Jahan A Rahman, Ran Xu, Esther Drill, Natasha Galasso, Nivetha Ganesan, Theresa Davey, Helen Hancock, Leslie Perez, Catherine Maccaro, Alexandra Bahgat, Evan Marzouk, Elizabeth Cathcart, Alison Moskowitz, Ariela Noy, Anita Kumar, Eric Jacobsen, David C Fisher, Neha Mehta-Shah, Youn H Kim, Michael Khodadoust, Nikita Kotlov, Anastasia Nikitina, Olga Mikhaylovna Plotnikova, Valeria Zubareva, Ksenia Zornikova, Nara Shin, Maria A Sorokina, Sandrine Degryse, Ekaterina Postovalova, Aleksander Bagaev, Kinga K Hosszu, Devin McAvoy, Jaap-Jan Boelens, Wenchao Wu, Zoe Ciantra, Jackson W Appelt, Christopher Trevisani, Sam Amaka, David M Weinstock, Santosha A Vardhana
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial. Nature medicine (2024)
Juan C Osorio, David A Knorr, Polina Weitzenfeld, Ning Yao, Maria Baez, Meghan DiLillo, Jahan A Rahman, Jacqueline F Bromberg, Michael A Postow, Charlotte E Ariyan, Mark E Robson, Jeffrey V Ravetch
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer. Research square (2024)
Mateusz Legut, Zoran Z Gajic, Maria Guarino, Zharko Daniloski, Jahan A Rahman, Xinhe Xue, Congyi Lu, Lu Lu, Eleni P Mimitou, Stephanie Hao, Teresa Davoli, Catherine Diefenbach, Peter Smibert, Neville E Sanjana
A genome-scale screen for synthetic drivers of T cell proliferation. Nature 603 (7902) (2022)